| ￥1875 | |
| L00957-0.5 | |
|
|
|
|
|
|
|
|
|
| Product Description |
The
CytoSinct CD19 Nanobeads, human, are used for in vitro enrichment or depletion of
CD19+ cells from fresh or frozen
peripheral blood mononuclear cells (PBMCs), leukapheresis products, or
single-cell suspension based on the surface expression of human CD19. To begin the isolation, Nanobeads are added to the cells. The cells/beads mixed suspension is loaded onto a CytoSinct Column placed in the CytoSinct Magnet, or other compatible columns with a magnet. The CD19+ cells labeled with Nanobeads are retained within the column and unlabeled cells (CD19- cells) are flushed out during the wash step. After removing the column from the magnetic field, the retained CD19+ cells can be eluted as the positively selected cell fraction. |
| Capacity |
|
||||||||||||
| Format | Supplied in phosphate-buffered saline (PBS), containing Human Serum Albumin (HSA) and Poloxamer 188. | ||||||||||||
| Components |
1 mL or 0.5 mL CytoSinct CD19 Nanobeads, human Nanobeads conjugated to monoclonal anti-human CD19 antibodies (isotype: chimeric IgG1). |
||||||||||||
| Storage & Stability | Store at 2 - 8 °C. Do not freeze. |
»
CD19+ B cells were enriched or depleted from human PBMCs. CD19+ cells were stained with antiCD19 (clone: 4G7) PE and gated on Live/hCD45+. »
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
